Author(s) and year | Sensitivity (95% CI) | Specificity (95% CI) | Positive LR (95% CI) | Negative LR (95% CI) | DOR (95% CI) |
---|---|---|---|---|---|
Presepsin | |||||
 Plesko 2016–1 | 0.81 [0.54, 0.94] | 0.28 [0.17, 0.43] | 1.13 [0.82, 1.56] | 0.68 [0.20, 2.27] | 1.67 [0.36, 7.67] |
 Plesko 2016–2 | 0.82 [0.56, 0.94] | 0.57 [0.42, 0.71] | 1.91 [1.25, 2.91] | 0.31 [0.10, 0.99] | 6.09 [1.37, 27.17] |
 Tanir Basaranoglu 2017 | 0.99 [0.92, 1.00] | 0.93 [0.86, 0.97] | 14.60 [6.51, 32.73] | 0.01 [0.001, 0.14] | 1606.09 [87.05, 29,633.96] |
 Baraka 2018 | 0.97 [0.79, 1.00] | 0.85 [0.71, 0.93] | 6.44 [3.16, 13.13] | 0.03 [0.002, 0.48] | 207.77 [11.09, 3892.29] |
 Bivariate summary estimates (95% CI) | 0.94 [0.74, 0.99] | 0.71 [0.35, 0.92] | 3.24 [1.14, 12.38] | 0.08 [0.01, 0.74] | 32.87 [2.12, 510.09] |
CRP | |||||
 Plesko 2016–1 | 0.28 [0.14, 0.49] | 0.95 [0.85, 0.98] | 5.43 [1.38, 21.38] | 0.76 [0.58, 0.99] | 7.17 [1.50, 34.24] |
 Plesko 2016–2 | 0.50 [0.29, 0.72] | 0.71 [0.58, 0.82] | 1.74 [0.92, 3.29] | 0.70 [0.42, 1.16] | 2.48 [0.81, 7.60] |
 Baraka 2018 | 0.76 [0.54, 0.90] | 0.66 [0.51, 0.79] | 2.26 [1.39, 3.69] | 0.36 [0.16, 0.82] | 6.33 [1.85, 21.72] |
 Bivariate summary estimates (95% CI) | 0.51 [0.24, 0.78] | 0.81 [0.53, 0.94] | 2.68 [0.51, 13.00] | 0.60 [0.23, 1.43] | 4.63 [2.16, 9.95] |
PCT | |||||
 Plesko 2016–1 | 0.80 [0.59, 0.91] | 0.68 [0.53, 0.80] | 2.47 [1.54, 3.97] | 0.30 [0.13, 0.71] | 8.18 [2.44, 27.43] |
 Plesko 2016–2 | 0.66 [0.42, 0.84] | 0.79 [0.67, 0.88] | 3.19 [1.67, 6.08] | 0.43 [0.22, 0.86] | 7.36 [2.14, 25.32] |
 Baraka 2018 | 0.97 [0.79, 1.00] | 0.80 [0.66, 0.89] | 4.93 [2.69, 9.04] | 0.03 [0.002, 0.51] | 150.18 [8.20, 2750.01] |
 Bivariate summary estimates (95% CI) | 0.76 [0.59, 0.88] | 0.76 [0.67, 0.83] | 3.17 [1.79, 5.18] | 0.32 [0.61, 0.14] | 11.88 [3.49, 40.47] |
 Bivariate summary estimates (95% CI) (Total) | 0.79 [0.60, 0.90] | 0.75 [0.61, 0.86] | 3.16 [1.54, 6.43] | 0.28 [0.66, 0.12] | 10.76 [4.31, 26.83] |